SCHEMBL1045324

SCHEMBL1045324

CC(C)[CH]CCO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12475284 0.78
SCHEMBL1942558 0.78
SCHEMBL988920 0.77 LMNA (0.39)
SCHEMBL7197208 0.73
SCHEMBL105067 0.72
SCHEMBL11199752 0.72
SCHEMBL167808 0.69
SCHEMBL11312587 0.69 TSHR (0.30)
SCHEMBL18134583 0.69
SCHEMBL4283553 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 157 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101331133-A Sulphonamidoaniline derivatives as Janus kinase inhibitors NOVARTIS AG (CH) 2008-12-24 CN claimed
US-20080261973-A1 Sulphonamidoaniline Derivatives Being Janus Kinase Inhibitors NOVARTIS AG (CH) 2008-10-23 US claimed
EP-1966210-A2 SULPHONAMIDOANILINE DERIVATIVES BEING JANUS KINASES INHIBITORS Novartis AG (CH) 2008-09-10 EP claimed
WO-2007071393-A2 SULPHONAMIDOANILINE DERIVATIVES BEING JANUS KINASES INHIBITORS NOVARTIS AG (CH) 2007-06-28 WO claimed
CN-116783204-A Modulators of cystic fibrosis transmembrane conductance regulator 弗特克斯药品有限公司 2023-09-19 CN disclosed
US-20230190730-A1 4-OXOQUINOLINE COMPOUND AND USE THEREOF AS PHARMACEUTICAL AGENT JAPAN TOBACCO INC. (JP) 2023-06-22 US disclosed
WO-2021121327-A1 SUBSTITUTED STRAIGHT CHAIN SPIRO DERIVATIVES JANSSEN PHARMACEUTICA NV (BE) 2021-06-24 WO disclosed
US-20200101061-A1 4-OXOQUINOLINE COMPOUND AND USE THEREOF AS PHARMACEUTICAL AGENT JAPAN TOBACCO INC. (JP) 2020-04-02 US disclosed
EP-3406596-A1 4-OXOQUINOLINE COMPOUND AND USE THEREOF AS HIV INTEGRASE INHIBITOR Japan Tobacco Inc. (JP) 2018-11-28 EP disclosed
EP-3405166-A1 HYDROPHOBIC TOPICAL COMPOSITIONS Edgewell Personal Care Brands, LLC (US) 2018-11-28 EP disclosed
US-20180265454-A1 Method for Producing 4-Oxoquinoline Compound JAPAN TOBACCO INC. (JP) 2018-09-20 US disclosed
EP-2750657-B1 BISUREA GELLING AGENTS AND COMPOSITIONS MILLIKEN & CO (US) 2018-03-21 EP disclosed
WO-1998027950-A1 ANTIPERSPIRANT GEL-SOLID STICK COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 1998-07-02 WO disclosed
WO-1998027949-A1 ANTIPERSPIRANT GEL-SOLID STICK COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 1998-07-02 WO disclosed
WO-1998027951-A2 ANTIPERSPIRANT GEL-SOLID STICK COMPOSITIONS SUBSTANTIALLY FREE OF SELECT POLAR SOLVENTS THE PROCTER & GAMBLE COMPANY (US) 1998-07-02 WO disclosed
WO-1998027955-A1 ANTIPERSPIRANT GEL-SOLID STICK COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 1998-07-02 WO disclosed
WO-1998028008-A1 PHARMACEUTICAL COMPOSITIONS CONTAINING GELLANTS IN THE FORM OF ALKYL AMIDES OF DI- AND TRI-CARBOXYLIC ACIDS THE PROCTER & GAMBLE COMPANY (US) 1998-07-02 WO disclosed
WO-1998027952-A1 METHODS OF MAKING LOW RESIDUE ANTIPERSPIRANT GEL-SOLID STICK COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 1998-07-02 WO disclosed
US-5750096-A SOLID NON-POLYMERIC GELLANT BASED ON 12-HYDROXYSTEARIC ACID; ANHYDROUS LIQUID CARRIER THE PROCTER & GAMBLE COMPANY (US) 1998-05-12 US disclosed
US-5744130-A COMPRISING ACTIVE MATERIAL, NONPOLYMERIC GELLANT, ANHYDROUS LIQUID CARRIER; LOW RESIDUE THE PROCTER & GAMBLE COMPANY (US) 1998-04-28 US disclosed